TRILYTE Drug Patent Profile
✉ Email this page to a colleague
When do Trilyte patents expire, and what generic alternatives are available?
Trilyte is a drug marketed by Aurobindo Pharma Usa and is included in one NDA.
The generic ingredient in TRILYTE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.
Summary for TRILYTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRILYTE at DailyMed |
Recent Clinical Trials for TRILYTE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gastroenterology Services, Ltd. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TRILYTE
US Patents and Regulatory Information for TRILYTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma Usa | TRILYTE | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION;ORAL | 076491-001 | Feb 5, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |